Fineotex Chemical Limited — Others, 14-11-2024: Statement of deviation(s) or variation(s) under Reg. 32

Fineotex Chemical Limited has confirmed that there is no deviation or variation in the utilization of funds raised through its preferential issue of equity shares and convertible warrants for the quarter ended September 30, 2024. The total amount raised is ₹192.60 crores, broken down into ₹142.62 crores from equity shares and ₹50.08 crores from convertible warrants. This statement, reviewed and approved by the Audit Committee, underscores the company's adherence to its funding objectives, which includes working capital requirements and business expansion. The announcement may positively influence investor sentiment, reflecting a commitment to transparency and proper governance.